Rosesta Medical is a Netherlands-based startup that aims to revolutionize the fertility industry with its innovative product line under the brand name
FERTI·LILY. Founded in
2020 by medical entrepreneur
Robert Stal, the company's flagship product is the
FERTI·LILY Conception Cup, developed in collaboration with renowned fertility specialist,
Dr. Maarten Wiegerinck. This soft, silicone cup is clinically proven to increase the chances of conception by an impressive +48%. The company also offers the
FERTI·LILY Conception Gel, a sperm-friendly personal lubricant aimed at enhancing the pleasure of conceiving.
With the trend of delayed family planning and declining fertility rates,
FERTI·LILY addresses the challenges faced by modern couples trying to conceive. The company's mission is to provide at-home solutions that empower couples to take control of their fertility without sacrificing intimacy. Exhibiting strong market traction, their products have received positive feedback from customers, with a rating of 4.4 out of 5 stars. The company has secured contracts to launch in over 30 countries through their distribution partners.
Operating in the
Health Care and
Manufacturing industries,
FERTI·LILY caters to a significant and growing market. As of now, the company has not disclosed any information about its last investment or investors.
For more information about
FERTI·LILY, interested parties can visit their website at
www.fertilily.com or reach out via email at
[email protected]. With a vision to contribute to countless 'little miracles',
FERTI·LILY is poised to make a meaningful impact in the years to come.
